carglumic acid has been researched along with Disease Models, Animal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Caldovic, L; Haskins, N; McNutt, M; Morizono, H; Senkevitch, E; Sonaimuthu, P; Tuchman, M; Uapinyoying, P | 1 |
Coleman, DN; Guo, S; Loor, JJ; Peng, A; Wang, H; Wang, M; Yu, Y; Zhang, H | 1 |
Cabrera-Luque, J; Caldovic, L; Morizono, H; Senkevitch, E; Tuchman, M | 1 |
Benenato, KE; Fortucci, S; Frassetto, A; Guey, LT; Hoar, K; Jacquinet, E; Jiang, L; Laureano, R; Liang, S; Lukacs, CM; Martini, PGV; Mihai, C; Park, JS; Presnyak, V; Tunkey, C; Yan, X; Yang, J; Yin, L; Zhu, X; Zhuo, J | 1 |
5 other study(ies) available for carglumic acid and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
Topics: Amino-Acid N-Acetyltransferase; Animals; Arginine; Citrulline; Dependovirus; Disease Models, Animal; Gene Transfer Techniques; Glutamates; Humans; Hyperammonemia; Mice; Mice, Knockout; Mutant Proteins; Urea; Urea Cycle Disorders, Inborn | 2021 |
N-Carbamylglutamate and l-Arginine Promote Intestinal Absorption of Amino Acids by Regulating the mTOR Signaling Pathway and Amino Acid and Peptide Transporters in Suckling Lambs with Intrauterine Growth Restriction.
Topics: Amino Acid Transport Systems; Amino Acids; Animals; Animals, Newborn; Arginine; Disease Models, Animal; Female; Fetal Growth Retardation; Glutamates; Intestinal Absorption; Membrane Transport Proteins; Nitric Oxide; Pregnancy; RNA, Messenger; Sheep, Domestic; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
A novel biochemically salvageable animal model of hyperammonemia devoid of N-acetylglutamate synthase.
Topics: Amino-Acid N-Acetyltransferase; Animals; Breeding; Disease Models, Animal; Female; Gene Order; Gene Targeting; Genotype; Glutamates; Humans; Hyperammonemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype | 2012 |
Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia.
Topics: Animals; Disease Models, Animal; Enzyme Replacement Therapy; Glutamates; Humans; Kinetics; Lipids; Liver; Methylmalonyl-CoA Decarboxylase; Mice; Mice, Knockout; Mice, Transgenic; Mitochondria; Nanoparticles; Propionic Acidemia; Protein Subunits; RNA, Messenger | 2020 |